Postural Orthostatic Tachycardia Syndrome: The Mayo Clinic Experience

Thieben, Mark J.; Sandroni, Paola; Sletten, David M.; Benrud-Larson, Lisa M.; Fealey, Robert D.; Vernino, Steven; Lennon, Vanda A.; Win-Kuang Shen; Low, Phillip A.
March 2007
Mayo Clinic Proceedings;Mar2007, Vol. 82 Issue 3, p308
Academic Journal
OBJECTIVE: To evaluate the prevalence and pathogenetic mechanisms of postural orthostatic tachycardia syndrome (POTS). PATIENTS AND METHODS: We reviewed the medical records of patients with POTS seen at the Mayo Clinic in Rochester, Minn, from January 1, 1993, through December 31, 2003. All patients were required to have had a full autonomic reflex screen. The results of the following additional tests were evaluated: thermo-regulatory sweat test, plasma catecholamine measurement, serum ganglionic (α3) acetylcholine receptor antibody detection, and 24-hour urinary sodium measurement. RESULTS: We identified 152 patients (86.8% female; mean ± SD age, 30.2±10.3 years) with a mean duration of symptoms of 4.1 years. The mean orthostatic heart rate increment was 44 beats/mm. Half the patients had sudomotor abnormalities (apparent on both the quantitative sudomotor axon reflex test and thermoregulatory sweat test), and 34.9% had significant adrenergic Impairment, indicating that at least half of the patients had a neuropathic pattern of POTS. In 13.8% of patients, onset was subacute, and ganglionic acetylcholine receptor antibody was detected in 14.6%, suggesting an autoimmune origin in at least 1 in 7 patients. Hyperadrenergic status was documented in 29.0% of patients (standing plasma norepinephrine level ≥600 pg/mL), and at least 28.9% were presumably hypovolemic (24-hour urinary sodium level <100 mEq/24h). The lack of correlation between urinary sodium and standing norepinephrine levels suggests that mechanisms other than hypovolemia accounted for the hyperadrenergic state. CONCLUSION: Our findings suggest a neuropathic basis for at least half the cases of POTS and that a substantial percentage of cases may be autoimmune. Hyperadrenergic and hypovolemic correlates are likely compensatory or exacerbating.


Related Articles

  • Nocturnal heartache. Saccoman, Joseph J.; R.M.D. // Cortlandt Forum;9/25/95, Vol. 8 Issue 9, p112 

    Discusses the possibility of paroxysmal supraventricular tachycardia or an arrhythmia secondary to an accessory pathway in a 36-year-old patient with nocturnal chest discomfort, palpitations, heavy feeling in the eyes and insomnia. Examinations performed; Differential diagnosis.

  • Monomorphic Outflow Tract Ventricular Tachycardia: Unique Presenting Manifestation of itelman's Syndrome. Vanga, Subba Reddy; Annapureddy, Chandra; Biria, Mazda; Lakkireddy, Dhanunjaya // JAFIB: Journal of Atrial Fibrillation;Jan2010, Vol. 1 Issue 10, p606 

    The article presents a case study of a 27-year-old male with Gitelman's syndrome who manifested an outlflow tract ventricular tachycardia (OTVT). After multiple emergency room (ER) consultations with symptoms of light headedness, palpations, and near syncope, the patient was presented for...

  • Isolated Junctional Tachycardia in a Child After Noncardiac Surgery: An Uncommon Clinical Presentation. Sriram, Chenni; White, Roger; Madhavan, Malini; Cannon, Bryan // Pediatric Cardiology;Dec2011, Vol. 32 Issue 8, p1234 

    Isolated junctional tachycardia is rare in children but has been reported after cardiac surgery. To date, it has not been reported after noncardiac surgery. This report describes the case of a 3-year-old boy with no cardiac history who experienced transient junctional tachycardia after a right...

  • Amiodarone for post-operative junctional ectopic tachycardia. Plumpton, Kevin; Justo, Robert; Haas, Nikolaus // Cardiology in the Young;Feb2005, Vol. 15 Issue 1, p13 

    Background: Post-operative junctional ectopic tachycardia is a transient, but potentially life threatening, rapid automatic tachyarrhythmia that requires urgent and adequate treatment. In our study, we review retrospectively the use and efficacy of amiodarone for this arrhythmia over an 8-year...

  • ECG of the month. Regan, Claire; Regan, Martin // British Journal of Cardiac Nursing;Oct2014, Vol. 9 Issue 10, p475 

    The article describes the case of a 48 year old female admitted to the coronary care unit (CCU) after a cardiac arrest outside the hospital and another arrest in the emergency department. She had a past medical history of bipolar disorder, depression and paroxysmal atrial fibrillation and takes...

  • First reported case of recurrent tachycardia-induced cardiomyopathy due to atrial flutter. David, M.; Rothman, S.; Shapiro, T. // QJM: An International Journal of Medicine;May2014, Vol. 107 Issue 5, p383 

    No abstract available.

  • Non-Re-Entrant Atrioventricular Nodal Tachycardia. Haman, Ludek; Praus, Rudolf; Parizek, Petr // Military Medicine;Aug2009, Vol. 174 Issue 8, p866 

    Supraventricular tachycardia caused by AV nodal dual conduction is usually re-entry tachycardia. We report a case of a 40-year-old man with incessant supraventricular tachycardia caused by simultaneous conduction via slow and fast AV nodal pathway. The patient was successfully treated with...

  • Clinical importance of transesophageal electrophysiologic study in the management of supraventricular tachycardia in children. Erdoğan, İlkay; Özer, Sema; Karagöz, Tevfik; Şahin, Murat; Çeliker, Alpay // Turkish Journal of Pediatrics;Nov/Dec2009, Vol. 51 Issue 6, p578 

    Transesophageal electrophysiologic study (TEEPS) is a semi-invasive method widely used for evaluation of symptoms related to arrhythmia. In this study, we aimed to determine the accuracy of TEEPS in the diagnosis and differentiation of mechanisms of supraventricular tachycardias (SVTs) by...

  • Beyond postural tachycardia syndrome. Mustafa, Hossam I.; Robertson, David // Journal of Neurology, Neurosurgery & Psychiatry;Mar2010, Vol. 81 Issue 3, p237 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the pathophysiology of postural tachycardia syndrome (POTS), synaptic junction, and norepinephrine transporter (NET) dysfunction.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics